Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab in Crohn's disease: early and long-term treatment.
Armuzzi A, De Pascalis B, Fedeli P, De Vincentis F, Gasbarrini A. Armuzzi A, et al. Among authors: fedeli p. Dig Liver Dis. 2008 Jul;40 Suppl 2:S271-9. doi: 10.1016/S1590-8658(08)60537-X. Dig Liver Dis. 2008. PMID: 18599000
High prevalence of hyperplastic colonic polyps in acromegalic subjects.
Martino A, Cammarota G, Cianci R, Bianchi A, Sacco E, Tilaro L, Marzetti E, Certo M, Pirozzi G, Fedeli P, Pandolfi F, Pontecorvi A, Gasbarrini G, De Marinis L. Martino A, et al. Among authors: fedeli p. Dig Dis Sci. 2004 Apr;49(4):662-6. doi: 10.1023/b:ddas.0000026315.91800.b2. Dig Dis Sci. 2004. PMID: 15185875
Infliximab in the treatment of steroid-dependent ulcerative colitis.
Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. Armuzzi A, et al. Among authors: fedeli p. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):231-3. Eur Rev Med Pharmacol Sci. 2004. PMID: 15638236 Clinical Trial.
Growth hormone in inflammatory bowel disease.
De Pascalis B, Bianchi A, Satta MA, Lupascu A, Mentella MC, Leo D, Fiore F, Fedeli P, Pontecorvi A, Pola P, Melina D, Gasbarrini A, De Marinis L, Armuzzi A. De Pascalis B, et al. Among authors: fedeli p. Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):13-6. Eur Rev Med Pharmacol Sci. 2006. PMID: 16494105 Review.
Helicobacter pylori infection and ischaemic heart disease.
Cammarota G, Pasceri V, Papa A, Cianci R, Gasbarrini A, Fedeli P, Cremonini F, Fedeli G, Maseri A, Gasbarrini G. Cammarota G, et al. Among authors: fedeli g, fedeli p. Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S304-6. Ital J Gastroenterol Hepatol. 1998. PMID: 10077760 Review.
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Cammarota G, Cannizzaro O, Tursi A, Papa A, Gasbarrini A, Cuoco L, Cianei R, Armuzzi A, Fedeli P, Fedeli G, Gasbarrini G. Cammarota G, et al. Among authors: fedeli g, fedeli p. Aliment Pharmacol Ther. 1998 Jun;12(6):539-43. doi: 10.1046/j.1365-2036.1998.00341.x. Aliment Pharmacol Ther. 1998. PMID: 9678813 Clinical Trial.
106 results